Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraneware Regulatory News (CRW)

Share Price Information for Craneware (CRW)

Share Price is delayed by 15 minutes
Get Live Data
1,138.00    28.00 (2.52%)
Bid:
1,138.00
Ask:
1,146.00
Spread: 8.00 (0.703%)
Market Cap: £389.62m
CRW Live PriceLast checked at - London Stock Exchange

Intraday Craneware Share Chart

Trading Update

15 Jul 2014 07:00

RNS Number : 2877M
Craneware plc
15 July 2014
 



 Craneware plc

("Craneware", "the Group" or the "Company")

Trading Update and Notice of Results

 

 

15 July 2014 - Craneware (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, provides an update on trading for the year ended 30 June 2014.

 

The Board is pleased to confirm the increased sales activity reported earlier in the year  has delivered a record sales performance for the Group with the total value of contracts signed in the year increasing to over  $70m (FY13: $38.5m), an increase in excess of 80% on the prior year.

 

In accordance with the Group's revenue recognition policy, which is focussed on long term sustainable growth and mitigates against year on year fluctuations in the total value of contracts signed, the vast majority of the revenue from these sales has not been recognised in the year to 30 June 2014, and will instead benefit future years. Accordingly the Group expects to report revenues in a range of $42.2m to $43m (FY13: $41.5m) and deliver an adjusted EBITDA in a range of $12.8m to $13.2m (FY13: $12.4m).

 

The market for revenue integrity solutions continues to develop with larger and more complex hospital systems becoming an increasing part of both current year sales and the pipeline of sales opportunities. We continue to invest in our sales organisation to ensure we are optimally positioned to take advantage of this growing market opportunity. Management believes as the fiscal and regulatory pressures on US hospitals continue to grow, the strength and relevance of our unique suite of solutions will increase in this market environment, giving us confidence in continued future growth.

 

Keith Neilson, CEO of Craneware plc commented, "We are delighted to announce a record sales year for the Group, with a year on year increase of over 80% in the total value of contracts signed in the year, demonstrating the ongoing strength of our market position. The current sales success gives Craneware certainty over contracted revenue and associated profits upon which to build future growth."

 

The Company will announce its Full Year Results on 16th September 2014.

 

For further information, please contact:

 

Craneware plc

Peel Hunt

Newgate Threadneedle

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7653 9850

Keith Neilson, CEO

Dan Webster

Caroline Forde

Craig Preston, CFO

Richard Kauffer

Fiona Conroy

Heather Armstrong

 

About Craneware

 

Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta, Arizona, Massachusetts and Tennessee employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance for healthcare organisations. Craneware's market-driven, SaaS solutions help hospitals and other healthcare providers more effectively price, charge, code and retain earned revenue for patient care services and supplies. This optimises reimbursement, increases operational efficiency and minimises compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMGMNNDMGDZM
Date   Source Headline
19th Aug 20114:40 pmRNSSecond Price Monitoring Extn
19th Aug 20114:35 pmRNSPrice Monitoring Extension
11th Aug 20113:49 pmRNSHolding(s) in Company
19th Jul 20117:00 amRNSTrading Update and Contract Wins
2nd Jun 20117:00 amRNSInvestor and Analyst Presentation
2nd Jun 20117:00 amRNSCraneware InSight Contract Win
31st May 201112:24 pmRNSTotal Voting Rights
24th May 20117:00 amRNSDirector Declaration
28th Apr 20112:42 pmRNSTotal Voting Rights
27th Apr 201112:25 pmRNSBlocklisting Interim Review
27th Apr 201110:02 amRNSHolding(s) in Company
19th Apr 20115:28 pmRNSHolding(s) in Company
8th Apr 20114:18 pmRNSHolding(s) in Company
7th Apr 20114:49 pmRNSHolding(s) in Company
7th Apr 20113:52 pmRNSBlocklisting Application
7th Apr 20118:53 amRNSHolding(s) in Company
5th Apr 20112:11 pmRNSDirector Shareholding & Issue of Equity
1st Apr 20115:27 pmRNSAdditional Listing
31st Mar 20115:51 pmRNSTotal Voting Rights
25th Mar 20114:27 pmRNSHolding(s) in Company
25th Mar 20113:45 pmRNSDividend Currency Election
24th Mar 20117:00 amRNSAdditional Listing
17th Mar 20115:19 pmRNSDirector/PDMR Shareholding
15th Mar 201111:32 amRNSAdditional Listing
10th Mar 20115:27 pmRNSAdditional Listing
10th Mar 20115:22 pmRNSHolding(s) in Company
10th Mar 20115:18 pmRNSHolding(s) in Company
2nd Mar 20117:00 amRNSDirector & PDMR Shareholding
28th Feb 20114:31 pmRNSAdditional Listing
28th Feb 20113:46 pmRNSDirector/PDMR Shareholding
28th Feb 20117:00 amRNSHalf Yearly Report
18th Feb 20117:00 amRNSAcquisition of ClaimTrust
28th Jan 20118:26 amRNSHolding(s) in Company
25th Jan 20117:00 amRNSTrading Update & Notice of Results
21st Dec 20104:38 pmRNSAdviser - Change of Name
12th Nov 20108:19 amRNSDividend Currency Election
9th Nov 20102:34 pmRNSHolding(s) in Company
9th Nov 20102:22 pmRNSHolding(s) in Company
2nd Nov 20107:00 amRNSAGM Statement
19th Oct 20107:10 amRNSBlocklisting Interim Review
19th Oct 20107:00 amRNSPosting of Annual Report and Accounts
8th Oct 201012:44 pmRNSHolding(s) in Company
28th Sep 20107:00 amRNSContract Win for Supplies ChargeLink
22nd Sep 20107:00 amRNSHolding(s) in Company
9th Sep 20102:47 pmRNSDirector/PDMR Shareholding
8th Sep 20107:00 amRNSDirector/PDMR Shareholding
6th Sep 20107:00 amRNSFinal Results
10th Aug 20107:00 amRNSNotice of Final Results
14th Jul 20107:00 amRNSTrading Update
9th Jul 20107:00 amRNSLaunch of ADR Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.